慢性阻塞性肺病患者的血清素-3:一个元分析
1Department of Emergency Medicine, Shaoxing Seventh People's Hospital, Shaoxing, China.
Biomolecules & biomedicine
|August 16, 2024
概括
在患有慢性阻塞性肺病 (COPD) 的患者中,血清上素-3 (PTX-3) 水平升高,特别是在急性恶化期间. 这一发现表明PTX-3可能是COPD严重程度和疾病状况的有用生物标志物.
科学领域:
- 肺部医学 肺部医学
- 生物标志物 生物标志物
- 炎症 炎症是一种炎症.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题.
- 血清素-3 (PTX-3) 是一种炎症标记物,在慢性慢性病中具有潜在的相关性.
- 之前对COPD中PTX-3水平的研究已经产生了不一致的结果.
研究的目的:
- 进行元分析,评估COPD患者与健康对照者的血清PTX-3水平.
- 为了比较COPD急性恶化 (AECOPD) 和稳定的COPD患者之间的血清PTX-3水平.
- 为了确定COPD严重程度和恶化状态的潜在生物标志物.
主要方法:
- 在PubMed,Embase,Web of Science,Wanfang和CNKI数据库中的系统文献搜索.
- 包括17项研究,包括996名AECOPD患者,1414名稳定的COPD患者和1016名健康对照.
- 应用随机效应模型进行元分析,并进行子组和元回归分析.
主要成果:
- 慢性肺炎患者的血清PTX-3水平明显高于健康对照组 (SMD:0.51,P<0.001).
- 与稳定的COPD患者相比,AECOPD患者的血清PTX-3水平显著更高 (SMD:0.58,P<0.001).
- 亚组和元回归分析表明,年龄,性别或吸烟状况对这些发现没有重大影响.
结论:
- 与健康个体相比,COPD患者的血清PTX-3水平较高.
- 血清PTX-3水平升高在COPD急性恶化期间特别明显.
- PTX-3显示为评估COPD严重程度和恶化状态的潜在生物标志物.
相关概念视频
01:30Pneumonia III: Complications and Assessment
193
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:27Pneumothorax-II
127
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
127